Application Information

This drug has been submitted to the FDA under the reference 201046/001.

Names and composition

"RANOLAZINE" is the commercial name of a drug composed of RANOLAZINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
201046/001 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 500MG
201046/002 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 1GM
208174/001 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 500MG
208174/002 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 1000MG
208862/002 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 1GM

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021526/001 RANEXA RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 1GM
021526/002 RANEXA RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 500MG
201046/001 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 500MG
201046/002 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 1GM
208174/001 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 500MG
208174/002 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 1000MG
208862/002 RANOLAZINE RANOLAZINE TABLET, EXTENDED RELEASE/ORAL 1GM

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved